Tonix Pharmaceuticals (TNXP) Registration Filing summary

Company overview and business model

• Incorporated in Nevada with principal executive offices in Chatham, New Jersey.

• Operates in the pharmaceutical sector, as indicated by the company name and registration details.

Management team and governance

• Seth Lederman serves as Chief Executive Officer and principal executive officer.

• Bradley Saenger is Chief Financial Officer and principal accounting officer.

• Board includes directors Richard Bagger, Margaret Smith Bell, David Grange, Adeoye Olukotun, Newcomb Stillwell, Carolyn E. Taylor, James Treco, and James Hunter.

Offering details and pricing

• Registration statement filed on Form S-3 for a proposed public offering of securities from time to time after the effective date.

• Securities may be offered on a delayed or continuous basis under Rule 415.

• The filing is an amendment to re-file Exhibit 23.1 and does not modify the prospectus.